Date | Document |
---|---|
21/12/2012 | Newsletter-December 2012 |
21/12/2012 | Fibrosis Update |
15/11/2012 | Results of Annual General Meeting |
15/11/2012 | AGM Presentation to Shareholders |
07/11/2012 | FerriScan gains ground with US Insurance Payers |
31/10/2012 | Appendix 4C - quarterly |
23/10/2012 | FerriScan contracted for two new Clinical Trials |
18/10/2012 | FDA requests a broader Indication for Use for Ferriscan |
15/10/2012 | Annual Report to shareholders |
15/10/2012 | Notice of Annual General Meeting Proxy Form |
15/10/2012 | Notice of Annual General Meeting/Proxy Form |
28/09/2012 | Full Year Statutory Accounts |
31/08/2012 | Preliminary Final Report |
31/07/2012 | Appendix 4C - quarterly |
11/07/2012 | FDA Submission for HepaFat Scan & update Liver Fibrosis Test |
30/04/2012 | Appendix 4C - quarterly |
05/04/2012 | Update on HepaFat Scan and Liver Fibrosis Test |
19/03/2012 | Company Secretary Appointment/Resignation |
29/02/2012 | Half Yearly Report and Accounts |
31/01/2012 | Appendix 4C - quarterly |